Eurocine Vaccines AB Stock Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Sales 2022 | 0.07 0 | Sales 2023 | 0 0 | Capitalization | 9.09M 0 |
---|---|---|---|---|---|
Net income 2022 | -20M - | Net income 2023 | -18M - | EV / Sales 2022 | 119,226,800 x |
Net cash position 2022 | 14.24M 0 | Net cash position 2023 | 1.04M 0 | EV / Sales 2023 | 1,608,986,800 x |
P/E ratio 2022 |
-0.93
x | P/E ratio 2023 |
-0.41
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 4.17% |
Managers | Title | Age | Since |
---|---|---|---|
Hans Arwidsson
CEO | Chief Executive Officer | 66 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 86 | 11-12-31 | |
Hans Arwidsson
CEO | Chief Executive Officer | 66 | 03-12-31 |
Pär Thuresson
BRD | Director/Board Member | 64 | 03-12-31 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |